BCM
CALA

Beddow Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Beddow Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,138
Closed -$112K – 58
2020
Q4 		$112K Hold
1,138
– – 0.08% 54
2020
Q3 		$78K Sell
1,138
-237
-17% -$20.7K 0.07% 49
2020
Q2 		$145K Hold
1,375
– – 0.13% 47
2020
Q1 		$122K Hold
1,375
– – 0.11% 45
2019
Q4 		$157K Buy
1,375
+812
+144% +$61.1K 0.1% 46
2019
Q3 		$35K Hold
563
– – 0.02% 46
2019
Q2 		$44K Buy
+563
New +$63.9K 0.03% 47

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Beddow Capital Management's CALA Position: Q1 2021 in Review

Beddow Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 1,138 shares — an estimated $112K sold.

Beddow Capital Management first reported a position in CALA in Q2 2019 and held it in 7 quarters. The position peaked at $157K in Q4 2019. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

  • Beddow Capital Management reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
  • Beddow Capital Management sold 1,138 Calithera Biosciences, Inc shares in Q1 2021, an estimated $112K.
  • Beddow Capital Management first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 7 quarters.
  • Beddow Capital Management's Calithera Biosciences, Inc position peaked at $157K in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Beddow Capital Management's 13F filing for Q1 2021, filed 8 Apr 2021.